The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,354,442 Cooperative Agreement under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Texas at Dallas (UTD) on September 1, 2024. The project aims to develop a system integrating vagus nerve stimulation (VNS) with lower limb rehabilitation to enhance recovery of gait function in individuals with chronic spinal cord injury (SCI). The project's UG3...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $462,296 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of Louisville to conduct research on propriospinal plasticity and recovery after incomplete spinal cord injury. The project aims to investigate the anatomical plasticity exhibited by long-ascending propriospinal neurons (LAPNs) following spinal cord injury, the impact of silencing...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to identify the electrophysiological characteristics of spinal motor neurons during the recovery stages following a spinal cord injury (SCI) in mouse models. The $470,293 award to The Research Foundation For The State University Of New York, from July 1, 2025 to June 30, 2027, will...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA Program 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders", provides $427,625.00 to study whether electrical stimulation can enhance the capacity of neural stem cell transplants to improve recovery from chronic spinal cord injury. The primary goal is to determine if electrical stimulation supports the survival and differentiation of stem...
This $1,195,789 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on the safety and efficacy of transcutaneous electrical stimulation for recovery in acute spinal cord injury syndromes. The award was made on July 1, 2025 to The Regents of the University of California, San Francisco, which is a prominent academic medical center and research institution. The research aims to investigate medical solutions for the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on evaluating the effects of spinal cord stimulation (SCS) interventions on bladder function after spinal cord injury (SCI). The $238,500 award, with a project period from December 2024 to November 2026, will support research conducted by the University of Pittsburgh to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,735,024.00 to Wayne State University to develop a non-invasive infrared light therapy and medical device to treat spinal cord injury (SCI). The award aims to attenuate the acute injury and inflammatory response in the initial early phase following SCI, which can lead to neuronal...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $151,559 to Rensselaer Polytechnic Institute (RPI) from August 3, 2024 to July 31, 2026. The project aims to develop innovative magnetically responsive drug delivery electrospun fibers to improve regeneration after spinal cord injury (SCI). Specifically, the research will focus...
This federal Cooperative Agreement award, totaling $1,594,319.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Texas Health Science Center at Houston (UTHealth). The award aims to develop and test an innovative, non-invasive device called Breathing-Controlled Electrical Stimulation (BREESTIM) for the management of neuropathic pain after spinal cord injury. The project...
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an $11.2 million project grant to the University of Pittsburgh to define the mechanisms of pain relief associated with dorsal root ganglion and spinal cord stimulation. This three-year grant will support research under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to advance understanding of neuromodulatory devices for chronic pain treatment. The University will conduct preclinical...